Cytori Therapeutics Announces Participation at the 2013 Stem Cell Meeting on the Mesa’s 3rd Annual Regen Med …

SAN DIEGO--(BUSINESS WIRE)--

Cytori Therapeutics, Inc. (CYTX) will give a company presentation at the 3rd Annual Regen Med Partnering Forum, part of the 2013 Stem Cell Meeting on the Mesa on Tuesday, October 15. In addition, Cytoris CEO Chris Calhoun will be participating on a conference panel on Monday, October 14.

The following are specific details regarding Cytoris presentation and panel participation at the conference:

Panel III: Financing Regenerative Medicine & Advanced Therapies

Cytori Therapeutics, Inc. Company Presentation

Both the presentation and the panel will be available live and will be available on the Webcasts page of Cytoris investor relations site approximately two weeks following the conference.

The 2013 Stem Cell Meeting on the Mesa conference is being organized by the Alliance for Regenerative Medicine (ARM), the California Institute for Regenerative Medicine and the Sanford Consortium for Regenerative Medicine with the intention of bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science into cures.

About Cytori

Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple ischemic conditions. These therapies are made available to the physician and patient at the point-of-care by Cytoris proprietary technologies and products, including the Celution System product family. http://www.cytori.com

Link:
Cytori Therapeutics Announces Participation at the 2013 Stem Cell Meeting on the Mesa’s 3rd Annual Regen Med ...